期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 52, 期 2, 页码 445-455出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm8012213
关键词
-
资金
- NIH [CA 114053, CA 127369, CA 55791]
- Roswell Park Alliance Foundation
- RPCI [P30CA 16056]
In our present study, 3-(1'-m-iodobenzyloxyethyl)pyropheophorbide-a methyl ester 1, 3-(1'-m-iodobenzyloxyethyl)- 17(2)-{(2-deoxy)glucose}pyropheophorbide-a 2, and 3-(1'-m-iodobenzyloxyethyl)-17(2)-{(1-deoxy)-galactose} pyropheophorbide-a 3 were synthesized and converted into the corresponding I-124-labeled analogues by reacting the intermediate trimethyltin analogues with (NaI)-I-124. Photosensitizers 1-3 were evaluated for the PDT efficacy in C3H mice bearing RIF tumors at variable doses and showed a significant long-term tumor cure. Among the compounds investigated, the non-carbohydrate analogue 1 was most effective. These results were in contrast to the in vitro data, where compared to the parent analogue the corresponding galactose and glucose derivatives showed enhanced cell kill. Among the corresponding I-124-labeled analogues, excellent tumor images were obtained from compound 1 in both tumor models (RIF and Colon-26) and the best tumor contrast was observed at 72 h after injection. Conjugating a glucose moiety to photosensitizer 1 initially diminished its tumor uptake, whereas with time the corresponding galactose analogue showed improved tumor contrast.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据